These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25101832)

  • 1. Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance.
    Rohilla R; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016 Jun; 23(5):1645-61. PubMed ID: 25101832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate-based materials for targeted delivery of drugs and genes to the liver.
    Ahmed M; Narain R
    Nanomedicine (Lond); 2015 Jul; 10(14):2263-88. PubMed ID: 26214359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of Hepatoprotective Liver Specific Targeted Drug Delivery: A Review on Novel Herbal and Formulation Approaches in the Management of Hepatotoxicity.
    Rohilla S; Bhatt DC
    Curr Drug Targets; 2018; 19(13):1519-1549. PubMed ID: 29299986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel materials which possess the ability to target liver cells.
    Chen Z; Xiao L; Liu W; Liu D; Xiao YY; Chen J; Liu X; Li WD; Li W; Cai BC
    Expert Opin Drug Deliv; 2012 Jun; 9(6):649-56. PubMed ID: 22480167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver cell-targeted delivery of therapeutic molecules.
    Kang JH; Toita R; Murata M
    Crit Rev Biotechnol; 2016; 36(1):132-43. PubMed ID: 25025274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug targeting to the diseased liver.
    Poelstra K; Prakash J; Beljaars L
    J Control Release; 2012 Jul; 161(2):188-97. PubMed ID: 22370583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting the bioengineering versatility of lactobionic acid in targeted nanosystems and biomaterials.
    Alonso S
    J Control Release; 2018 Oct; 287():216-234. PubMed ID: 30149049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin.
    Wang SN; Deng YH; Xu H; Wu HB; Qiu YK; Chen DW
    Eur J Pharm Biopharm; 2006 Jan; 62(1):32-8. PubMed ID: 16226883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of polymer-drug conjugates in organ-specific delivery systems.
    Paramjot ; Khan NM; Kapahi H; Kumar S; Bhardwaj TR; Arora S; Mishra N
    J Drug Target; 2015 Jun; 23(5):387-416. PubMed ID: 25720345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient hepatic delivery of drugs: novel strategies and their significance.
    Mishra N; Yadav NP; Rai VK; Sinha P; Yadav KS; Jain S; Arora S
    Biomed Res Int; 2013; 2013():382184. PubMed ID: 24286077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications.
    Wu J; Nantz MH; Zern MA
    Front Biosci; 2002 Mar; 7():d717-25. PubMed ID: 11861224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Avenues in Treatment of Liver Diseases: Role of Nanotechnology.
    Bhuyan M; Kaur M; Kaushal U; Nagpal M; Singh M; Aggarwal G
    Curr Drug Targets; 2023; 24(4):320-331. PubMed ID: 36658702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents.
    Wu J; Liu P; Zhu JL; Maddukuri S; Zern MA
    Hepatology; 1998 Mar; 27(3):772-8. PubMed ID: 9500706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles for human liver-specific drug and gene delivery systems: in vitro and in vivo advances.
    Kasuya T; Kuroda S
    Expert Opin Drug Deliv; 2009 Jan; 6(1):39-52. PubMed ID: 19236207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of Hepatic Macrophages by Therapeutic Nanoparticles.
    Colino CI; Lanao JM; Gutierrez-Millan C
    Front Immunol; 2020; 11():218. PubMed ID: 32194546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
    Gupta U; Jain NK
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porous nanoparticles in drug delivery systems.
    Arayne MS; Sultana N
    Pak J Pharm Sci; 2006 Apr; 19(2):158-69. PubMed ID: 16751130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
    Hunter AC; Elsom J; Wibroe PP; Moghimi SM
    Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes.
    Arangoa MA; Düzgüneş N; Tros de Ilarduya C
    Gene Ther; 2003 Jan; 10(1):5-14. PubMed ID: 12525832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The liver-cell specific drug delivery system].
    Goto M
    Nihon Rinsho; 1994 Aug; 52(8):2214-24. PubMed ID: 7933613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.